Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
Prakash DoddapattarRishabh DevMadankumar GhatgeRakesh B PatelManish JainNirav DhaneshaSteven R LentzAnil K ChauhanPublished in: Circulation research (2022)
Genetic deletion of PKM2 in myeloid cells or limiting its nuclear translocation reduces atherosclerosis by suppressing inflammation and enhancing efferocytosis.